Skip to content
- CDC website, https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
- “Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2 DS2 -VASc Score for Thromboembolic Risk Assessment Analysis From the National Cardiovascular Data Registry’s Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry”, Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org DOI: 10.1161/CIRCOUTCOMES.116.003476.
- Redfors, Björn, et al. “Patients with atrial fibrillation who are not on anticoagulant treatment due to increased bleeding risk are common and have a high risk of stroke.” JACC: Clinical Electrophysiology 3.12 (2017): 1369-1376.
- January, Craig T., et al. “2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.” Journal of the American College of Cardiology 64.21 (2014): e1-e76.
- Go et al, prevalence of diagnosed atrial fibrillation in adults, jama, may 9 2001, vol 285, no 18.
- Blackshear, Joseph L., and John A. Odell. “Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.” The Annals of thoracic surgery 61.2 (1996): 755-759.
- S.S. Chugh, R. Havmoeller, K. Narayanan, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation, 129 (2014), pp. 837-847